NIH Grants

Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward interdisciplinary projects that leverage AI, machine learning, and advanced data science to address pressing questions in biomedical and public health research. It seeks to advance fundamental scientific and engineering contributions across disciplines to solve key health problems.

NIH R25 Summer Research Education Experience Program is a grant from the National Institutes of Health (NIH) that funds universities and institutions of higher education to provide summer research experiences in environmental health sciences to high school students, college undergraduates, and science teachers. Administered through the National Institute of Environmental Health Sciences (NIEHS), the program aims to attract young people to scientific careers and help teachers communicate about the scientific process more effectively. Eligible applicants are U.S. institutions eligible for NIH grants. The application deadline was March 17, 2026.

The NIA Academic Leadership Career Award (K07, No Independent Clinical Trial) is a career development award from the National Institute on Aging (NIH) that supports established investigators who want to expand their expertise in aging-related research and academic leadership. Awards provide up to $150,000 per year to fund protected research and mentoring time. Eligible applicants are investigators with a doctoral degree (PhD, MD, or equivalent) who are named PD/PI on an active R01 or equivalent NIA grant, devote 25-50% full-time professional effort to the award, and are U.S. citizens or permanent residents. The application deadline is March 20, 2026.

Mobile Health (mHealth): Technology and Outcomes in Low and Middle Income Countries is a grant from the Fogarty International Center at NIH that funds research on mobile health technologies and their outcomes in low and middle income countries. Administered as an R21/R33 Phased Innovation Award, this funding opportunity supports studies that leverage mHealth tools to address health challenges in resource-limited settings. Participating NIH components include FIC, NEI, NIBIB, NICHD, NIDCD, NIMH, and NCI. Applications must align with the mission of the participating institutes. The program accommodates clinical trial optional designs. Award amounts vary by application and institute. The deadline for the most recent cycle was March 20, 2026.

The FDT-BioTech program is a joint NSF NIH and FDA initiative that catalyzes biomedical technological innovation through foundational development of methods and algorithms relevant to digital twins and synthetic humans. The program supports inherently interdisciplinary research projects that underpin the mathematical and engineering foundations behind the development and use of digital twins and synthetic data in biomedical and healthcare applications with a particular focus on digital in silico models used in the evaluation of medical devices and to advance regulatory sciences. Priority research areas include computational representations of physiological systems verification validation and uncertainty quantification transferability and generalizability across populations ethics security and privacy considerations and validation mechanisms for digital twin models. The program incorporates AI and machine learning as key enabling technologies for creating responsive digital twin models. All proposals must address regulatory science benefits and ethical implications. This program is distinct from the NSF SCH Smart Health program which focuses broadly on AI for health research and from ARPA-H programs which target specific clinical applications.

Notice of Special Interest (NOSI): Encouraging Women's Health Research within the NIDCD Mission Areas is sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD) / National Institutes of Health (NIH). This notice solicits grant applications seeking to improve women's health across the lifespan within the scope of NIDCD's mission.

LAUNCH Program is sponsored by National Institutes of Health (NIH). The LAUNCH program supports the training of future global health researchers by providing early career researchers in the U.S. an opportunity for immersion in the wide-ranging health conditions and challenges experienced in international low-resource settings and to partner with local health researchers.

NLM Information Resource Grants to Reduce Health Disparities and Promote Health for All (G08 Clinical Trial Not Allowed) is sponsored by National Library of Medicine (NIH). This funding opportunity supports the development of information resources and services that provide accurate health information to populations experiencing health disparities and their providers, to improve health literacy, decision-making, and reduce disparities.

Notice of Special Interest (NOSI): Administrative Supplements for Research on Women's Health in Low- and Middle-Income Countries (LMICs) is sponsored by Office of Research on Women's Health (ORWH), National Institutes of Health (NIH). This NOSI announces the availability of administrative supplements to existing NIH grants to support research on women's health in LMICs. This could include research on women's health cancers within the scope of an existing grant.

Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (RFA-EB-26-003) is sponsored by National Institutes of Health (NIH), National Institute of Biomedical Imaging and Bioengineering (NIBIB). This Notice of Funding Opportunity (NOFO) solicits applications to enhance bioengineering and imaging research capacity, technology innovation, education and research training, and opportunities for scientific growth at Historically Black College and Universities (HBCUs).

Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) (PAR-25-342) is sponsored by National Institutes of Health (NIH). This opportunity funds research on interventions addressing health and healthcare disparities related to non-communicable and chronic diseases in Latin America, with the goal of improving health outcomes.

Novel Experiential Technologies Assisting Individual Learning Hubs (NExT AI Hubs) is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) - NIH. This initiative seeks to advance NICHD's mission through a Centers program that will carry out research on understudied, highly innovative, and high-risk research topics related to the impact of Artificial Intelligence (AI) technologies on developmental outcomes in children at r…

Research Council of Finland (RCF) – National Institutes of Health (NIH) Partnership Program (PA-26-085) is sponsored by NIH Fogarty International Center. This program funds collaborative health research projects between U.S. and Finnish universities. While not explicitly focused on traditional medicine or complementary health, research in global health could be part of the collaborative projects.

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) is sponsored by U.S. Department of Health and Human Services; National Library of Medicine; National Institutes of Health (NIH). This program supports innovative, scalable bioinformatics research with broad biomedical impact. This can include AI applications within bioinformatics, translational bioinformatics, and computational biology.

Research Grants in Clinical Informatics (R01 Clinical Trial Optional) is sponsored by U.S. Department of Health and Human Services, National Institutes of Health (NIH). This NIH funding opportunity supports innovative clinical informatics research to transform health data into actionable knowledge. While broad, it can include projects leveraging AI for data analysis and integration to advance biomedical research.

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) is sponsored by National Cancer Institute (NCI), National Institutes of Health (NIH). This funding opportunity invites investigator-initiated studies addressing mechanisms by which incretin mimetics, specifically GLP-1 or dual GLP-1/GIP-1 receptor agonists, impact cancer risk. The focus includes reported effects on thyroid, prostate, and other cancer risks. The NOFO also aims to attract scientists from other fields to study incretin mimetic effects on cancer biology.

Pre-application: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Technologies to Understand the Control of Organ Function by the Peripheral Nervous System (OT1) (RFA-RM-16-002) is sponsored by National Institutes of Health (NIH). This funding opportunity invites pre-applications for SPARC Technologies to Understand the Control of Organ Function by the Peripheral Nervous System. It's a required first step for those interested in submitting a full application to the companion OT2 FOA (RFA-RM-16-003). The SPARC program aims to provide a scientific foundation for neuromodulation devices and stimulation protocols.

Institutional Mentored Career Development Award (K12) is sponsored by National Institutes of Health (NIH). This program supports institutional career development awards designed to prepare newly trained clinicians who have made a commitment to independent research careers and to facilitate their transition to more advanced support mechanisms, such as K08 and K23.

R21 Exploratory/Developmental Grant is a grant from the National Institutes of Health (NIH) that funds early-stage, high-risk research projects across biomedical and behavioral science categorical program areas. Awards support projects of up to two years with a maximum of $275,000 in total direct costs, with no more than $200,000 in any single year. Preliminary data are not required for most opportunities. Research strategies may not exceed six pages. Multiple NIH institutes and centers participate, and investigators should consult NIH scientific staff during concept development to confirm that the R21 mechanism is appropriate for their project.

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) is sponsored by National Center for Advancing Translational Sciences (NCATS)/National Institutes of Health (NIH). This R03 grant supports pilot projects that investigate understudied proteins associated with rare diseases. Leukodystrophies are rare diseases, and research into the proteins involved in their pathogenesis would be highly relevant.

NCATS program (PAR-25-157) supporting development of innovative technologies for translational science including AI/ML-driven drug discovery, high-throughput screening automation, computational target identification, and novel assay platforms. Funds exploratory research that creates new tools, methods, and technologies to overcome specific translational bottlenecks in the drug development pipeline. Part of NCATS' broader mission that has enabled over 45 promising new drugs to move into clinical trials through partnerships with academia, industry, and patient advocacy groups. NCATS maintains a pharmaceutical collection of nearly every human-approved drug and automated solutions for rapid drug repurposing screening including for emerging infectious diseases.

Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) is sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD) / NIH. This funding opportunity supports early-stage dissemination and implementation (D&I) research projects in NIDCD mission areas, including hearing and balance. It aims to support projects that will set a foundation for a high-quality, D&I focused R01.

New Generation of Glucose Control Technologies Incorporating AI/ML is a funding announcement from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at NIH that will solicit applications for research to improve open- and closed-loop diabetes control systems for Type 1 diabetes. Research priorities include innovations in analyte sensing, novel hormone formulation and delivery, AI and machine learning-driven algorithms, and digital twin modeling to enhance glycemic control and quality of life. Awards will use the R01 research project grant activity code. Applications are not yet being solicited but the notice was issued to allow potential applicants time to develop meaningful collaborations. Eligible applicants include universities, nonprofits, Tribal governments, for-profit organizations, and federal agencies.

Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) is sponsored by National Institutes of Health (NIH). The NIH offers various funding opportunities for behavioral and social sciences research. While this specific R21 announcement title doesn't explicitly mention 'consumer behavior marketing science,' R21 grants support exploratory/developmental research, and consumer behavior aspects could be relevant within broader translational science, especially related to health behaviors. Researchers are encouraged to filter announcements by agency, topic, eligibility, or deadline on Grants.gov.

Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3, Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) (NCI also participating). This funding opportunity supports the development of biomarkers or clinical outcomes from digital health technology for remote monitoring in clinical trials.

Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development is sponsored by National Institutes of Health (NIH) / National Cancer Institute (NCI). This funding opportunity focuses on digital health approaches that can significantly advance the assessment, monitoring, and understanding of cancer risk factors and determinants and increase participant reach and engagement in cancer research.

Notice of Intent to Publish a Funding Opportunity Announcement for Impact of Technology and Digital Media Exposure Usage on Child and Adolescent Development (NOT-HD-25-008) is sponsored by National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). NICHD intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on the impact of technology and digital media (TDM) on children and adolescents, including potential broader effects on their families and communities.

Research on the Impact of Technology and Digital Media on Children and Adolescents (Forecasted) is sponsored by National Institutes of Health (NIH) - Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). NICHD intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on the impact of technology and digital media on children and adolescents.

Notice of Intent to Publish a Funding Opportunity Announcement for Impact of Technology and Digital Media Exposure Usage on Child and Adolescent Development is sponsored by National Institutes of Health (NIH) - Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This NOFO will solicit applications for research on the impact of technology and digital media on children and adolescents, including potential broader effects on their families and communities.

Notice of Intent to Publish a Funding Opportunity Announcement for Impact of Technology and Digital Media Exposure Usage on Child and Adolescent Development is sponsored by National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This funding opportunity will solicit applications for research on the impact of technology and digital media on children and adolescents, including potential broader effects on their families and communities. It aims to address the urgent need to understand how TDM use and exposure impacts children's health and development, as well as how it alters interactions between children and their family members, peers, and society at large.

BRAIN Initiative: Production and distribution facilities for brain cell type-specific access reagents (U24 Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. This BRAIN Initiative Notice of Funding Opportunity (NOFO) aims to support the establishment of facilities at minority-serving institutions (MSIs) and Institutional Development Award (IDeA)-eligible institutions for scaled production and distribution of brain cell type-specific …

Instrumentation Grant Program for Resource-Limited Institutions (RLI-S10) is a grant from the National Institutes of Health (NIH), administered by the National Institute of General Medical Sciences (NIGMS), that supports acquisition of modern scientific instruments for research and education at resource-limited institutions. Awards range from ,000 to ,000. Instruments may support basic, translational, clinical, or biomedically related behavioral science research and may also be used in upper-level and graduate courses. This program targets institutions with limited existing research infrastructure, helping to enhance their biomedical research and education capacity. The deadline for the current cycle is July 2, 2026.

Native American Research Centers for Health (NARCH) is sponsored by Indian Health Service (IHS), National Institute on Minority Health and Health Disparities (NIMHD), National Institutes of Health (NIH), U.S. Department of Health and Human Services (HHS). This program offers grants for new or continued Native American Research Centers for Health, which support health-related research, research career enhancement, and research infrastructure enhancement activities to meet the health needs of American Indian/Alaska Native (AI/AN) communities nationwide.

Native American Research Centers for Health (NARCH) is sponsored by Indian Health Service, National Institute on Minority Health and Health Disparities (NIMHD), National Institutes of Health (NIH), U.S. Department of Health and Human Services (HHS). This program offers grants for new or continued Native American Research Centers for Health, which support health-related research, research career enhancement, and research infrastructure enhancement activities to meet the health needs of American Indian/Alaska Native (AI/AN) communities.

Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID) - NIH. The TRACs program aims to develop the next generation of TB researchers and catalyze multidisciplinary and innovative TB science by providing expertise and resources to facilitate basic and clinical TB research.

HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development Study - Research Project Sites (Collaborative U01- Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH). Supports research on the development of the human brain and child development, which may include studies related to chronic pain in children.

NINDS Research Education Programs for Residents and Fellows in Neurology and Neurosurgery (R25) is sponsored by NIH National Institute of Neurological Disorders and Stroke (NINDS). This program supports institutions to develop and implement research education and training programs for clinical residents and fellows in neurological sciences, including neurosurgery, to foster careers as physician-scientists.

Notice of NCATS Participation in Notice of Funding Opportunity (NOFO) PA-25-304 NIH Exploratory/Developmental Research Project Grant (Parent R21 Clini... is sponsored by National Center for Advancing Translational Sciences (NCATS)/National Institutes of Health (NIH). This notice indicates NCATS's participation in the NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) program, highlighting areas of interest for translational science research within this mechanism.

HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) HEAL Initiative. This funding opportunity supports early-stage discovery research for new pain targets within the understudied druggable proteome as part of the NIH HEAL (Helping to End Addiction Long-term) Initiative, which aims to address the opioid overdose crisis and improve pain management.

Minor Use Minor Species Development of Drugs (R01) (PAR-24-216) is sponsored by U.S. Food and Drug Administration (FDA) / National Institutes of Health (NIH). This grant supports the development and potential approval of new animal drugs for uncommon diseases (minor uses) in major species or to treat minor species. It covers routine safety, effectiveness, manufacturing, and toxicology studies.

Global Collaborative Research Training on Non-Communicable Diseases and Disorders Across the Lifespan is sponsored by National Institutes of Health (NIH) - Fogarty International Center. This initiative supports rigorous institutional research training programs for low- and middle-income country (LMIC) scientists that enhance collaborative NIH research with U. S. scientists on specific noncommunicable diseases (NCDs), disorders, and health conditions.

Growing Data-science Research in Africa to Stimulate Progress (GRASP) is sponsored by National Heart, Lung, and Blood Institute (NHLBI) / NIH. The GRASP program supports data-science research in Africa to stimulate progress. While the provided information is an award notice, it indicates an active program with a performance end date in July 2026, suggesting ongoing or upcoming related opportunities. The NIH supports a diverse mix of research projects in Sub-Saharan Africa.

NIBIB Technology Development Network Coordinating Centers is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH. This Notice of Funding Opportunity (NOFO) will solicit applications for NIBIB Technology Development Network Coordinating Centers. These Coordinating Centers are designed to bring scientific and engineering communities together to solve translational problems.

Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain is sponsored by National Center for Advancing Translational Sciences (NCATS), National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH). This program funds community-led research to enhance culturally grounded, strengths-based, effective, and sustainable interventions addressing overdose, substance use, mental health, and pain in Native communities. While focused on Native communities, many of these are rural and the research focus aligns with the query.

Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain is sponsored by National Institutes of Health (NIH) - National Center for Advancing Translational Sciences, National Institute on Drug Abuse. This program provides funding for community-led research to enhance culturally grounded, strengths-based, effective, and sustainable interventions addressing overdose, substance use, mental health, and pain in Native communities.

Funding Opportunity Announcement – NIBIB Technology Development Network Coordinating Centers (RFA‑EB‑26‑001) is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH. Funding Opportunity Announcement for NIBIB Technology Development Network Coordinating Centers is a grant from the National Institutes of Health (NIH) through the National Institute of Biomedical Imaging and Bioengineering (NIBIB) that will fund Coordinating Centers designed to …

NIH/AHRQ Digital Healthcare Solutions R21/R33 Grants is sponsored by National Institutes of Health (NIH) and Agency for Healthcare Research and Quality (AHRQ). This program supports the development and implementation of digital tools that enhance healthcare quality, safety, and efficiency. It aims to accelerate the integration of technology into real-world healthcare settings, empowering researchers, providers, and innovators to improve patient outcomes through data-driven care, AI-based decision support, and smart clinical workflows.

Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional) is sponsored by AHRQ NIH. This program supports the development and implementation of digital healthcare solutions, including AI/ML clinical decision support, generative AI for clinical workflows, smart point-of-care tools, and AI-based safety alerts, to improve healthcare quality, safety, and efficiency.

NIH Accelerator Program is sponsored by National Institutes of Health (NIH) (Collaborative effort with Prisma Health Education and Research Institute, Clemson University, University of South Carolina School of Medicine Greenville, and the Addiction Medicine Center). This is an intensive mentoring program for faculty investigators seeking NIH funding. The program aims to strategically position early-career investigators to develop complete and competitive NIH grant applications.

Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) (multiple institutes including NHLBI, NIMHD). This funding opportunity invites small business concerns to submit Small Business Innovation Research (SBIR) grant applications to develop products, processes, or services aimed at improving health access and reducing/eliminating health disparities in populations that experience…

NIH Director's Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional) (RFA-RM-27-003) is sponsored by National Institutes of Health (NIH) Common Fund. This award supports individual scientists or groups proposing bold, groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new paradigms in infectious biology and beyond.

NIHR NICE rolling funding opportunity (EME Programme) is sponsored by NIHR (National Institute for Health and Care Research). The NIHR NICE Efficacy and Mechanism Evaluation (EME) Programme funds high-quality studies that address research recommendations from NICE guidance published or updated in the last five years. Projects must focus on health-related outcomes and fill clear evidence gaps.

Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) is sponsored by NIH Fogarty International Center. This program supports institutions in low-and middle-income countries to strengthen their research administration capacity for global health research. While primarily for non-U. S. institutions, UC Davis Global Affairs could potentially collaborate or provide expertise.

Global Infectious Disease Research Training Program is sponsored by Fogarty International Center at NIH. Global Infectious Disease Research Training Program is a grant from the Fogarty International Center at NIH that funds research training programs focused on infectious diseases predominantly endemic in or significantly impacting people in low- and middle-income countries (LMICs).

Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed) is sponsored by U.S. Department of Health and Human Services, National Institutes of Health (NIH). This grant supports collaborative research on health disparities and NCDs in Latin America and U. S. Hispanic/Latino populations, emphasizing cross-national partnerships.

The Global Infectious Disease Research Training Program (D43) is a grant from the Fogarty International Center and NIAID at the NIH that funds collaborative research training programs to strengthen infectious disease research capacity in low- and middle-income countries (LMICs). Priority areas include antimicrobial resistance (AMR) and infectious disease surveillance, particularly at African institutions. Applications must be submitted jointly by a U.S. institution of higher education and an equivalent non-U.S. institution in an LMIC. Awards range from $250,000 to $1,500,000 per year. The application deadline is August 6, 2026. This is an ongoing funding opportunity announcement with multiple application receipt dates.

Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) Fogarty International Center. This program encourages joint applications from low- and middle-income country (LMIC) and U. S. institutions for collaborative training programs to strengthen the capacity of LMIC institutions to conduct infectious disease research (not including HIV/AIDS).

Global Infectious Diseases (GID) Research Training Program (D43 Clinical Trial Optional) is sponsored by NIH Fogarty International Center. This initiative supports rigorous advanced research training programs for low- and middle-income country (LMIC) scientists on infectious diseases that pose a potential threat to the U. S. and present special opportunities for research that are not readily available in the U.

Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial Optional) is sponsored by National Institute on Minority Health and Health Disparities (NIMHD), National Institutes of Health (NIH). This grant supports a coordinating center for the Research Centers in Minority Institutions (RCMI) program, which aims to enhance the research capacity of institutions that serve underrepresented minority populations.

Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed) (PA-27-037) is sponsored by National Institutes of Health (NIH). This award supports promising graduate students as they complete their doctoral research training and transition into mentored postdoctoral career development opportunities in research areas relevant to the missions of participating NIH Institutes and Centers.

NIHHIS Heat Tabletop Design Challenge is sponsored by National Integrated Heat Health Information System (NIHHIS), NOAA's Climate Program Office, and NOAA's Office of Atmospheric Research (OAR). This challenge invites community leaders to develop Situational Manuals for tabletop exercises to build resilience to extreme heat and its compounding and/or cascading impacts.

Health and Extreme Weather Research Award Program is sponsored by National Institutes of Health (NIH) / National Science Foundation (NSF) through the Natural Hazards Center at the University of Colorado Boulder. This NIH-NSF funded program offers awards to support the collection of perishable, health-relevant data within six months of extreme weather events.

NIH Director's New Innovator Award is sponsored by National Institutes of Health (NIH). This award, part of the High-Risk, High-Reward Research program, supports early career investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the NIH miss…

NIH Director's New Innovator Award (DP2) is sponsored by NIH Common Fund. Supports unusually innovative research from early career investigators who are within 10 years of their terminal degree or within 10 years of completing their clinical residency, who have not yet received a research project grant (R01) or equivalent peer-reviewed grant.

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH). This program supports small molecule drug discovery and development for disorders of the nervous system, from hit-to-lead chemistry through Phase I clinical testing. It provides both funding and in-kind support.

NIH HEAL Initiative Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH). NIH HEAL Initiative Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) is a grant from the National Institutes of Health that funds investigators developing small molecule …

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) is sponsored by NIH National Institute of Neurological Disorders and Stroke (NINDS). This program supports the discovery and development of small molecule drugs for disorders of the nervous system, which can include AD/ADRD. It provides a comprehensive pipeline for therapeutic development from target validation to clinical trials.

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) is sponsored by National Institute of Neurological Disorders and Stroke (NINDS)/NIH. This program supports small molecule drug discovery and development for disorders of the nervous system, including neurodegenerative diseases. It is part of the NIH Blueprint for Neuroscience Research.

Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed) is sponsored by NIH Fogarty International Center. The program's goal is to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) by enhancing functional resources for HIV research. It encourages collaborative applications from U.

NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI is sponsored by National Institutes of Health (NIH). The National Library of Medicine (NLM) invites applications for innovative predoctoral and postdoctoral training programs that prepare the next generation of researchers in biomedical informatics, data science, and artificial intelligence/machine learning (AI/ML).

NIH Director's Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH). This award supports exceptionally innovative and unconventional research projects that have the potential to create new paradigms or break existing ones. It is designed to support unusually bold and broad approaches to address important problems in biomedical research.

NIH Director's Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional) RFA-RM-27-003 is sponsored by National Institutes of Health (NIH). This award supports exceptionally innovative and unconventional research projects that have the potential to create new paradigms or break existing ones. This can include research leading to new diagnostic approaches.

Small Business Programs (SBIR & STTR) (Omnibus Solicitation) is sponsored by National Institutes of Health (NIH). While primarily for small businesses, universities can partner with small businesses through STTR programs. This omnibus solicitation supports research and development in biomedical/behavioral research areas, including health tech/AI. It covers AI for digital health, such as AI diagnostics or mobile health apps, and AI techniques for characterizing and minimizing errors in health-related datasets. This could be relevant for early-stage validation of commercial AI for fracture detection.

Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs (Omnibus Solicitations) is sponsored by National Institutes of Health (NIH) Office of Research on Women's Health (ORWH). The NIH SBIR and STTR programs are committed to increasing investments in small businesses engaged in research and development on women's health.

Small Business Technology Transfer (STTR) Program (Parent STTR [R41/R42]) is sponsored by National Institutes of Health (NIH), Department of Health and Human Services (HHS), Centers for Disease Control (CDC). This omnibus solicitation supports cooperative research and development between small businesses and non-profit research institutions to advance early-stage biomedical commercialization. It is designed to foster technology transfer.

NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA). This funding opportunity invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications.

NCI SBIR/STTR Omnibus Grant Solicitations is sponsored by National Cancer Institute (NCI) - NIH. The NCI SBIR/STTR program offers grants for investigator-initiated projects within the NIH mission related to cancer technology development. While the primary focus is cancer, areas like digital health, technologies for cancer prevention, and behavioral health interventions are included. A precision wellness healthtech for Black women could be relevant if it has a strong connection to cancer prevention, early detection, or improving outcomes for cancer disparities.

Small Business Innovation Research and Small Business Technology Transfer Programs is sponsored by National Institutes of Health (NIH). NIH's SBIR and STTR programs support research and development in small businesses, with a focus on biomedical/behavioral research areas, including health tech and AI. These programs aim to stimulate technological innovation and increase private sector commercialization of innovations.

NIA Small Business Interest Areas: Biomarkers, research tools, diagnostics, imaging technologies, and AI/ML methods for early detection and monitoring of Alzheimer's Disease (AD), AD-Related Dementias (ADRD), and Age-Related Cognitive Decline is sponsored by National Institute on Aging (NIA) - NIH. NIA Small Business Interest Areas: Biomarkers, research tools, diagnostics, imaging technologies, and AI/ML methods for early detection and monitoring of Alzheimer's Disease (AD), AD-Related Dementias (ADRD), and Age-Related Cognitive Decline is sponsored by National Institute o…

NIA Small Business Programs (SBIR & STTR) is sponsored by National Institute on Aging (NIA) NIH. The NIA Small Business Programs (SBIR & STTR) provide early-stage funding for aging-related research and development (R&D) to small businesses. This includes a significant budget for interventions preventing or treating Alzheimer's disease (AD) and AD-related dementias (ADRD).

Small Business Innovation Research and Small Business Technology Transfer Programs (NIH) is sponsored by National Institutes of Health (NIH). NIH's SBIR and STTR programs support research and development in small businesses, focusing on innovations for women's health research and other biomedical/behavioral research areas. This includes AI tools for medical diagnostics and other health-related applications.

PHS 2023 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) is sponsored by National Institutes of Health (NIH). This NIH SBIR omnibus solicitation is for small businesses proposing projects that include a clinical trial. Causal inference is a critical methodology in clinical trials for evaluating the effectiveness of interventions and understanding treatment effects, making it highly relevant to this funding opportunity.

NIA Small Business Interest Areas (SBIR/STTR) is sponsored by National Institutes of Health (NIH) - National Institute on Aging (NIA). The NIA is interested in proposals to develop and validate technologies that enhance the health and well-being of older adults. Areas of high interest include assistive devices, robotics, sensors, digital health products, and technologies to enhance care, support aging in place, improve care coordination and management, enhance quality of life, or reduce caregiving burden.

Small Business Innovation Research (SBIR) Program is sponsored by National Institute on Aging (NIA), National Institutes of Health (NIH). The NIA SBIR program funds small businesses to develop and validate technologies that enhance the health and well-being of older adults, with high interest in technologies addressing unmet needs, improving care delivery, or reducing caregiver burden. This includes AI/ML methods for early detection and monitoring, assistive devices, robotics, sensors, and digital health products.

Small Business Innovation Research (SBIR) Program Phase I is sponsored by National Institutes of Health (NIH) National Institute on Aging (NIA). This program supports small businesses in developing technologies for aging-related health issues, including AI applications in medical procedures and solutions addressing Alzheimer's disease (AD) and AD-related dementias (ADRD) treatment and care. It aims to support healthy aging and aging in place, and develop interventions for aging-related diseases.

Small Business Technology Transfer Grant Parent STTR [R41/R42] Clinical Trial Optional is sponsored by National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA). This program expands funding opportunities for small businesses in the federal innovation research and development arena. It requires a formal collaboration between a small business and a non-profit U.S. research institution for cooperative R&D. The goal is to stimulate technological innovation and increase commercialization of R&D.

Small Business Innovation Research (SBIR) Grants (R43 and R44) is sponsored by National Institute on Aging (NIA), National Institutes of Health (NIH). This program supports research and development of aging- and health-focused products and services by small business concerns that may ultimately lead to commercialization. This includes innovative tools, technologies, and interventions to prevent, diagnose, treat, monitor, or slow progression of AD/ADRD, cognitive decline, age-related sleep disorders, and delirium. Also includes technologies and interventions that promote healthy aging, support aging in place of choice, improve care delivery, or reduce caregiving burden, such as assistive devices, robotics, sensors, digital health products, and technologies to enhance care.

SBIR & STTR Grants (NIH) is sponsored by National Institutes of Health (NIH). The NIH SBIR and STTR programs are a major source of early-stage capital for technology commercialization in the United States, supporting small businesses in developing innovative biomedical technologies. This includes health tech/AI and diagnostics. NIH provides grant opportunities for small businesses in any biomedical or behavioral research area that falls within the agency's mission to improve human health.

PHS 2023 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Optional) is sponsored by National Institutes of Health (NIH). This solicitation supports cooperative research and development between small businesses and non-profit research institutions (e. g. , universities or federally funded research centers) for Small Business Technology Transfer (STTR) grant applications.

National Institute on Aging (NIA) Small Business Programs (SBIR & STTR) is sponsored by National Institute on Aging (NIA), NIH. The NIA Small Business Programs support small businesses developing digital health and sensing technologies that address factors impacting the aging population, as well as related conditions like Alzheimer's disease and related dementias. This includes innovative tools, technologies, and interventions to prevent, diagnose, treat, monitor, or slow progression of age-related biobehavioral decline and conditions, and technologies that promote healthy aging and improve care delivery.

Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs (NIH) is sponsored by National Institutes of Health (NIH). NIH offers SBIR and STTR grant funding opportunities to small businesses for early-stage research and development in biomedical and behavioral research areas that align with NIH's mission to improve human health. While not exclusively agricultural, innovation in areas like agricultural health or biotechnologies with health implications could be relevant.

SBIR/STTR Programs (Parent Announcements) is sponsored by National Institutes of Health (NIH). The NIH SBIR and STTR programs provide non-dilutive funding for early-stage research and development in health and biomedical innovations. While parent announcements do not specify a topic, they link to identified topics of interest for each participating awarding component, including biotechnology. The programs encourage small businesses to engage in high-risk, innovative research with potential for future commercialization.

Small Business Innovation Research (SBIR) / Small Business Technology Transfer (STTR) - National Institutes of Health (NIH) is sponsored by National Institutes of Health (NIH). The NIH SBIR and STTR programs fund small businesses to engage in research and development that has the potential for commercialization, particularly in biomedical, health tech, diagnostics, and therapeutic research.

Small Business Innovation Research (SBIR) Program (Phase I R43) (Clinical Trial Optional) is sponsored by National Institutes of Health (NIH). The NIH SBIR program provides non-dilutive funding for early-stage research and development projects by small businesses that have the potential for commercialization, particularly those that align with the mission of various NIH institutes and centers.

Small Business Technology Transfer (STTR) Program is sponsored by U.S. Small Business Administration (SBA) and participating federal agencies (e.g., NIH, NSF, DOE, DOD). The STTR program mirrors the SBIR program but requires formal collaboration between the small business and a non-profit research institution. It expands funding opportunities in the federal innovation research and development arena, encouraging technology transfer through cooperative research.

National Cancer Institute (NCI) SBIR/STTR Grants is a grant from the National Cancer Institute (NCI) of NIH that funds small businesses developing innovative cancer-related technologies and treatments. The program supports both SBIR (company-led) and STTR (research institution partnership) projects through investigator-initiated grants and NCI-defined contracts. Phase I grants are approximately $300,000 and Phase II awards exceed $2 million. Grant submissions are accepted three times per year; contracts are accepted once annually and focus on NCI priority areas. Eligible applicants are small businesses meeting NIH SBIR/STTR requirements proposing projects within NIH's research mission. Note: NIH SBIR/STTR legislative authority expired October 1, 2025; check NCI's site for current status.

Wearable Technologies to Facilitate Remote Monitoring of Cancer Patients Following Treatment is sponsored by National Cancer Institute (NCI) / NIH. This SBIR contract topic aims to accelerate the combination of wearable sensors and other remote monitoring technologies with sophisticated analytical approaches and user interfaces. The goal is to allow patients to be remotely monitored for cancer- or treatment-related adverse events, improving patient care and expanding clinical trials.

NIH Small Business Innovation Research (SBIR) Phase I (Parent R43/R44 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH). NIH funds AI in health, diagnostics, and biomedical research. Researcher-initiated ideas are proposed via the SBIR parent grant announcements, which do not specify a topic but link to identified topics of interest for each participating awarding component. Applications are accepted three times a year.

Small Business Innovation Research (SBIR) Program is sponsored by U.S. Small Business Administration (SBA) and participating federal agencies (e.g., NIH, NSF, DOE, DOD). The SBIR program, also known as America's Seed Fund, encourages small businesses to explore their technological potential and provides the incentive to profit from its commercialization. It offers non-dilutive capital for high-impact research and development (R&D) with commercialization potential.

Small Business Innovation Research (SBIR) Program and the Small Business Technology Transfer (STTR) Program (NIH Omnibus Solicitations) is sponsored by National Institutes of Health (NIH) Office of Research on Women's Health (ORWH). The NIH Office of Research on Women's Health (ORWH) actively encourages applications with a central focus on women's health within the NIH SBIR/STTR omnibus solicitations.